What Challenges Exist with Launching a Specialty Drug?


Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, speaks to the difficulties that face manufacturers who are launching a novel specialty product.

Gilbert: There are many challenges associated with orphan drugs, primarily because the patients and prescribers in these rare disease categories have not had treatment options before, as well as they are not familiar with working with a specialty pharmacy or manufacturer support programs that might be in place to help them with that process.

So, there’s a whole litany of new players involved, new processes, new programs they really know nothing about. It’s incumbent upon us, as specialty pharmacy partners, to educate not only the patient, their family, and caregivers, but the physicians as well as how to best gain access to the treatments for these patients.

Related Videos
Woman Physician Talking With Her Patient | Image Credit: LStockStudio - stock.adobe.com
A health visitor explaining a senior woman how to take pills - Image credit: Halfpoint | stock.adobe.com
Diabetes patient turn knob on end of insulin pen and dial up correct insulin dose for injection. Scale window on pen syringe showing number of units dose. Medical equipment is easy to self injection - Image credit: Orawan | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Krakenimages.com | stock.adobe.com
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Physician and kidneys
Image credit: gamjai - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.